Levosimendan therapy in decompensated chronic heart failure: Effects on natriuretic peptides and hemodynanic parameters

被引：0
|
作者：
Adamopoulos, S [1 ]
Parissis, JT [1 ]
Farmakis, D [1 ]
Kremastinos, DT [1 ]
机构：
[1] Univ Athens, Attikon Univ Hosp, Sch Med, Dept Cardiol 2, Athens, Greece
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2005年 / 104卷 / 03期
关键词：
D O I：
10.1016/j.ijcard.2005.04.034
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：357 / 358
页数：2
相关论文
共 50 条
  • [1] Natriuretic peptides in therapy for decompensated heart failure
    Natig Gassanov
    Esther Biesenbach
    Evren Caglayan
    Amir Nia
    Uwe Fuhr
    Fikret Er
    European Journal of Clinical Pharmacology, 2012, 68 : 223 - 230
  • [2] Natriuretic peptides in therapy for decompensated heart failure
    Gassanov, Natig
    Biesenbach, Esther
    Caglayan, Evren
    Nia, Amir
    Fuhr, Uwe
    Er, Fikret
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (03) : 223 - 230
  • [3] Natriuretic peptides in the therapy of acute decompensated heart failure
    Gassanov, N.
    Caglayan, E.
    Erdmann, E.
    Er, F.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (34-35) : 1738 - 1743
  • [4] Therapy of acute decompensated heart failure with levosimendan
    Müller, K
    Peters, A
    Zeus, T
    Hennersdorf, M
    Strauer, BE
    MEDIZINISCHE KLINIK, 2006, 101 : 119 - 122
  • [5] Levosimendan therapy in decompensated chronic heart failure: Favourable haemodynamic and neurohormonal effects but for how long?
    Parissis, JT
    Farmakis, D
    Kremastinos, DT
    EUROPEAN JOURNAL OF HEART FAILURE, 2006, 8 (02) : 215 - 215
  • [6] Relationship between B-type natriuretic peptide plasma levels and echocardiography parameters in decompensated chronic heart failure patients treated with levosimendan
    MB Ferri
    RH Passos
    M Knobel
    M Nigri
    EJA Figueiredo
    RD Morsch
    P Silveira
    JMA Souza
    A Perez
    Critical Care, 10 (Suppl 1):
  • [7] Effects of levosimendan on right ventricular function and immune activation in patients with decompensated chronic heart failure
    Bistola, V.
    Parissis, J.
    Kourea, K.
    Farmakis, D.
    Panou, F.
    Filippatos, G.
    Paraskevaidis, I.
    Kremastinos, D.
    EUROPEAN HEART JOURNAL, 2006, 27 : 628 - 628
  • [8] Effects of Levosimendan versus Dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure
    Adamopoulos, Stamatis
    Parissis, John T.
    Iliodromitis, Efstathios K.
    Paraskevaidis, Ioannis
    Tsiapras, Dimitrios
    Farmakis, Dimitrios
    Karatzas, Dimitrios
    Gheorghiade, Mihai
    Filippatos, Gerasimos S.
    Kremastinos, Dimitrios T.
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (01): : 102 - 106
  • [9] Acute therapy with Levosimendan (Simdax®) in decompensated heart failure NYHA IV
    Hardut, D.
    Eisenkoelbl, J.
    Elliott, P.
    Zweng, A.
    Weber, H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2006, 118 (17-18) : A41 - A42
  • [10] Short-term effects of levosimendan and prostaglandin E1 on hemodynamic parameters and B-type natriuretic peptide levels in patients with decompensated chronic heart failure
    Moertl, D
    Berger, R
    Huelsmann, M
    Bojic, A
    Pacher, R
    EUROPEAN JOURNAL OF HEART FAILURE, 2005, 7 (07) : 1156 - 1163
12345